BTG1 and acute myeloid leukemia: In this study, the inhibitory effect of decitabine on cell proliferation was weakened after BTG1 downregulation, suggesting that the inhibitory effect of decitabine on AML may be partially attributed to the hypomethylation and upregulation of BTG1.